|
Acute adverse reactions from gadolinium-based contrast agents used during MRI to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology.
After years of research regarding gadolinium-based contrast agents used during MRI being linked to the skin disease nephrogenic systemic fibrosis (NSF), the FDA has found the greatest risk in GE Healthcare’s Omniscan, Bayer HealthCare's Magnevist and Covidien’s Optimark.
Bayer reported that it has reached a settlement with some plaintiffs over claims that its MRI contrast agent Magnevist caused nephrogenic systemic fibrosis, a rare condition affecting people with kidney disease.
|
Lantheus Medical Imaging has launched Ablavar (gadofosveset trisodium), an injectable MR angiography (MRA) imaging agent used to evaluate aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease.
Following the switch from gadodiamide to gadobenate dimeglumine and gadopentetate dimeglumine, and the adoption of restrictive gadolinium-based contrast agent policies, no nephrogenic systemic fibrosis (NSF) cases were observed at two university health centers, according to a study in the October issue of Radiology.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.